Gurská Soňa Ph.D.
About me
I am working in the high throughput screening facility with focus on the testing of new chemical compounds, the implementation and validation of new biochemical and cell based assays into HTS. I am interested in identifying the active substances as potential drugs. I am experienced in liquid handling and robotic automation. Previously I was working in a field of mutagenesis and carcinogenesis at Cancer Reasearch Institute in Bratislava.
Journals
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances. RSC Advances. 2025, 15(55), 47565-47586, ISSN: 2046-2069, PMID: 41356712,
Synthesis and evaluation of cyclobut-3-ene-1,2-dione-3-hydrazones with benzothiazole moiety as novel anticancer agents inducing nonapoptotic oncosis-like cell death. Biomedicine & pharmacotherapy. 2025, ISSN: 0753-3322, PMID: 40763487,
Open positions
1 Molecular and Translational Medicine
| Project: | Drug repurposing for treatment and prevention of diseases |
|---|---|
| Supervisors: | Hajdúch Marián M.D., Ph.D., Gurská Soňa Ph.D. |
| Available: | 2 |
| Intended for: | Doctoral training |